RT Journal Article
SR Electronic
T1 Emergence of the D614A mutation in the spike protein of SARS-CoV-2: Imported cases to the South Korea
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.04.20184721
DO 10.1101/2020.09.04.20184721
A1 Ae Kyung Park
A1 Jin Sun No
A1 Eunkyung Shin
A1 Yoon-Seok Chung
A1 Il-Hwan Kim
A1 Byung-Hak Kang
A1 Gi-Eun Rhie
A1 Heui Man Kim
A1 Jeong-Min Kim
A1 Ye Eun Park
A1 Min Joon Kim
A1 Jae Sun Park
A1 Cheon-Kwon Yoo
A1 Junyoung Kim
YR 2020
UL http://medrxiv.org/content/early/2020/09/07/2020.09.04.20184721.abstract
AB We identified imported cases of a novel D614A mutation in the spike glycoprotein of SARS-CoV-2 in the South Korea. SARS-CoV-2 harboring the novel mutation was isolated from returning travelers from Uzbekistan. These results emphasized the possibility that new mutations have emerged in that area.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study did not require clinical trials.Funding StatementThis work was supported by a grant from the Korea Centers for Disease Control and Prevention [4837-301-210]Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I confirm all relevant ethical guidelines have been followed, and this study was approved by the institutional review board (IRB) of Korea Centers for Disease Control and Prevention (IRB no. 2011- 05CON-04-C).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe source data for the Table along with the Supplementary Table presented in this paper are available upon request.